Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Demographic, Clinical Characteristics, and Treatment Outcomes Associated With Dedifferentiated Liposarcoma Patients in China

NCT06115681 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT06115681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06115681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Demographic, Clinical Characteristics, and Treatment Outcomes Associated With Dedifferentiated Liposarcoma Patients in China
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
March 13, 2024
Completion date
May 15, 2024
Enrollment
1,390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dedifferentiated liposarcoma